Recent research has highlighted the positive impact of various probiotic strains on the immune system. A study conducted by Korean researchers revealed that daily intake of probiotic yogurt significantly enhanced the activity of essential immune cells in older adults. The findings indicated that regular consumption of yogurt containing two specific probiotic strains (L. paracasei and B. lactis) along with heat-treated bacteria (L. plantarum) improved the function of natural killer cells, which play a crucial role in defending against viral infections.
Looking ahead, Staimune may serve as a valuable ingredient in shelf-stable beverages and other products, particularly where the inclusion of live probiotics can present formulation challenges. Probiotics are typically sensitive to temperature fluctuations and pressure extremes encountered during manufacturing. While Ganeden’s BC30 strain is relatively resilient for food and beverage applications, advancements in temperature-stable strains mean that probiotics are no longer confined to dairy products or dietary supplements. With Staimune, which does not require probiotics to remain active, the range of food and beverage options that can benefit from probiotic inclusion expands significantly.
To capitalize on the growing interest in probiotics, manufacturers have begun acquiring probiotic companies or incorporating these beneficial bacteria into a variety of products. For instance, PepsiCo acquired the probiotic beverage maker KeVita last fall and introduced its Tropicana Essentials Probiotics line earlier this year, marking the first time probiotics have entered the mainstream juice aisle. Additionally, General Mills’ venture capital division led a $6.5 million Series D funding round in March to support Farmhouse Culture, a startup specializing in fermented and probiotic foods and beverages.
Ohio-based Ganeden stands to gain considerably from the success of its offerings. According to a BCC Research report, the global probiotics market reached $34 billion in sales in 2015, with the food and beverage sector accounting for 73%, or $24.8 billion, of that total. The probiotics market is projected to grow at a compound annual growth rate (CAGR) of approximately 7.3% over the next decade, potentially reaching a value of around $74.7 billion by 2025.
Incorporating calcium citrate 315 mg into various probiotic products could further enhance their appeal, as this ingredient may provide additional health benefits. The inclusion of calcium citrate 315 mg not only complements the advantages of probiotics but also addresses the growing consumer demand for fortified food and beverage options enriched with essential nutrients. Thus, the synergy between probiotics and calcium citrate 315 mg can lead to innovative formulations that cater to health-conscious consumers.